CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 61 filers reported holding CITIUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,821 | -60.5% | 23,116 | -30.7% | 0.00% | – |
| Q2 2023 | $40,015 | +2546.5% | 33,346 | +2481.0% | 0.00% | – |
| Q1 2023 | $1,512 | -83.4% | 1,292 | -88.8% | 0.00% | – |
| Q4 2022 | $9,088 | -99.9% | 11,504 | -0.4% | 0.00% | – |
| Q3 2022 | $13,979,000 | -31.3% | 11,553 | -47.8% | 0.00% | – |
| Q2 2022 | $20,360,000 | -17.9% | 22,130 | +59.7% | 0.00% | – |
| Q1 2022 | $24,804,000 | -63.7% | 13,857 | -68.8% | 0.00% | – |
| Q4 2021 | $68,422,000 | +23.4% | 44,430 | +62.7% | 0.00% | – |
| Q3 2021 | $55,431,000 | +32.7% | 27,306 | +127.6% | 0.00% | – |
| Q2 2021 | $41,760,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 135,508 | $472,000 | 0.15% |
| Wealth Advisory Solutions, LLC | 156,850 | $546,000 | 0.13% |
| Horst & Graben Wealth Management LLC | 75,722 | $264,000 | 0.07% |
| Miller Investment Management, LP | 50,000 | $174,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 44,655 | $155,000 | 0.02% |
| Triton Wealth Management, PLLC | 13,100 | $24,000 | 0.01% |
| Renaissance Technologies | 1,898,351 | $6,606,000 | 0.01% |
| B. Riley Wealth Management, Inc. | 19,000 | $66,000 | 0.01% |
| Virtu Financial LLC | 19,713 | $69,000 | 0.01% |
| WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 47,265 | $164,000 | 0.01% |